Last updated Nov 17, 2026. 4,422 unique records for ("vasoactive intestinal peptide"[Title] OR "vasoactive intestinal polypeptide"[Title] OR aviptadil[Title]). 2026 is a partial year. The Literature Activity score uses this title-restricted query (4,422 unique records). An unrestricted query for vasoactive intestinal peptide, vasoactive intestinal polypeptide, or aviptadil returns 16,060 records and is disclosed only for context. Cards on this page are identity and methods literature. Clinical papers on aviptadil, including ARDS and COVID-19 work, are not restated here, and this page does not assign a finished-drug identity to the vial. A PubChem name lookup for “vasoactive intestinal peptide” did not return a record; formula and mass are therefore omitted rather than taken from a named synthetic form. Source on PubMed
RC-VIP · Neuropeptide Research
RC-VIP
Neuropeptide Research
Vial sizes for laboratory supply, not a protocol.
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
- Catalog title
- RC-VIP | Neuropeptide Research
- Research focus
- Neuropeptide Research
- Also described as
- Vasoactive intestinal peptide (VIP)
- Format
- Lyophilized research peptide
- Catalog status
- In stock (public listing)
- Presentations
- 10 mg vial (inferred from catalog SKU)Catalog sizes, not a protocol
- Molecular formula
- No PubChem record assigned on this pageOmitted; name lookup for vasoactive intestinal peptide returned no record
- Molecular weight
- Not listed on this pageOmitted rather than taken from a named synthetic form
- Receptor context
- Endogenous neuropeptide and hormone first described as vasoactive intestinal peptidePublished identity literature; research context only
- Sequence
- Not reproduced hereSee primary literature / PubChem
- Researcher access
- Sign-in required to view pricing
- PubMed records
- 4,422 uniqueQuery above, Nov 17, 2026
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Neuropeptide Research
RC-VIP appears in the PEPTIDEA™ neuropeptide research collection with RC-DSIP and related listings.
Aviptadil is not assigned to the vial
Later literature discusses aviptadil as a named synthetic form of VIP that has been investigated clinically. This page records that naming fact only. It does not assign that form to the catalog vial and does not restate ARDS, COVID-19, or other clinical results.
10 mg catalog presentation
The public listing is a simple product. The 10 mg presentation is inferred from the catalog SKU rc-411-10. Catalog presentations are not a protocol.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
| Catalog title | RC-VIP | Neuropeptide Research |
|---|---|
| Category | Neuropeptide Research |
| Associated names | Vasoactive intestinal peptide (VIP); vasoactive intestinal polypeptide. Aviptadil is a named synthetic form discussed in later literature; this page does not assign that finished-drug identity to the catalog vial. |
| Format | Lyophilized research peptide |
| Public catalog status | In stock (as of Nov 17, 2026) |
| Catalog presentations | 10 mg vial (inferred from catalog SKU) — sizes of the research material, not a use protocol |
| Molecular formula | No PubChem record assigned on this page (Omitted; name lookup for vasoactive intestinal peptide returned no record, retrieved Nov 17, 2026) |
| Molecular weight | Not listed on this page (Omitted rather than taken from a named synthetic form) |
| InChIKey | Not listed on this page (PubChem) |
| Receptor context | VIP is an endogenous neuropeptide and hormone. Aviptadil is a named synthetic form that has been investigated clinically; this page does not assign that finished-drug identity to the catalog vial and does not restate those clinical results. Formula and mass are omitted because a PubChem name lookup for “vasoactive intestinal peptide” did not return a record, and a CID for aviptadil would imply a specific finished form. |
| Sequence | Not reproduced on this page. See primary literature and the PubChem record. |
| Pricing | Visible after researcher sign-in |
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
Said
This article reviews vasoactive intestinal peptide as a named endogenous peptide. It is included as identity literature, not as a use guide for this catalog vial.
Physiological discussion in the article is not restated on this page.
Sethi et al.
This methods chapter describes laboratory preparation of liposomal vasoactive intestinal peptide. It is included as methods and formulation-context literature, not as a development guide for this catalog item and not as a clinical paper.
Formulation procedures and any applied inferences in the chapter are not restated here.
Henning and Sawmiller
This review surveys published work on vasoactive intestinal peptide in cardiovascular physiology. It is included as literature-map context for the endogenous peptide. Cardiovascular findings in the review are not restated here and are not a use claim for this catalog material.
Physiological and clinical-context wording in the review is not reproduced on this page.
Research-profile note
Later papers discuss aviptadil as a named synthetic form of VIP that has been investigated clinically, including in respiratory-failure settings. Those papers are not cited as support for a use of this catalog vial, their results are not restated, and this page does not identify the vial as aviptadil.
This is an identity-boundary note, not a clinical summary.
Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query ("vasoactive intestinal peptide"[Title] OR "vasoactive intestinal polypeptide"[Title] OR aviptadil[Title]). Source on PubMed
Storage & handling
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
- Handle as a lyophilized research material intended for laboratory use only.
- Store according to the conditions printed on the label and in any compound document provided to approved researchers.
- Protect closed vials from moisture and unnecessary temperature swings.
- If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
- This material is not for human or veterinary use and is not medical advice.
Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.





